NCT05734417 is a NA clinical trial of Probiotic in Respiratory Tract Infections, sponsored by Min-Tze LIONG.

Who is sponsoring NCT05734417?

NCT05734417 is sponsored by Min-Tze LIONG.

What drugs are being tested in NCT05734417?

Interventions in NCT05734417: Probiotic, Placebo.

What condition does NCT05734417 study?

NCT05734417 studies Respiratory Tract Infections.

Is NCT05734417 still recruiting?

NCT05734417 is currently status unknown. Last updated 4 October 2023.

Last reviewed 2023-10-04 · How we verify

NCT05734417

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Probiotic Against Respiratory & Gastrointestinal Illnesses in Children

Status unknown NA Last updated 4 October 2023

What this trial tests

NA trial testing Probiotic in Respiratory Tract Infections in 120 participants. Status unknown.

Timeline

1 May 2023

Primary endpoint
1 March 2025

1 March 2025

Quick facts

Lead sponsor	Min-Tze LIONG
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	120
Start date	1 May 2023
Primary completion	1 March 2025
Estimated completion	1 March 2025
Sites	1 location across Malaysia

Drugs / interventions tested

Probiotic
Placebo

Conditions studied

Respiratory Tract Infections — all drugs for Respiratory Tract Infections →

Sponsor

Min-Tze LIONG

Who can join

Adults 1 Month to 84 Months, any sex, with Respiratory Tract Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to study the benefits of probiotics namely Bifidobacterium lactis subsp. infantis B8762 in treatment of respiratory and gastrointestinal illnesses in children, which are found common among pre-school children in Malaysia aged below 7-years old.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Therapeutic Potential of <i>Bifidobacterium longum</i> subsp. <i>infantis</i> B8762 on Gut and Respiratory Health in Infant.
Richmond RV, Mageswary U, Ali A, Taib F, et al · · 2025 · PMID 39941091 · DOI 10.3390/ijms26031323

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

NCT07529457 — Akk09 in Adults With Constipation · NA · not yet recruiting
NCT07507955 — Probiotics for Constipation Relief in Adults · NA · not yet recruiting
NCT07462481 — Probiotic Improve Constipation · NA · recruiting
NCT07511855 — Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term T · Phase 2 · not yet recruiting
NCT07474064 — Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC · Phase 2 · not yet recruiting

Other recruiting trials for Respiratory Tract Infections

Currently open trials in the same condition.

NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
NCT06715306 — Intravenous Versus Oral Treatment of the Main Acute Infections · NA · recruiting
NCT06472219 — PREDICATE Trial For Respiratory Tract Infections · Phase 3 · recruiting
NCT05914324 — Outpatient Pediatric Pulse Oximeters in Africa · NA · recruiting
NCT06579170 — Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada · active not recruiting

Other Min-Tze LIONG trials

Trials by the same sponsor.

NCT07511855 — Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term T · Phase 2 · not yet recruiting
NCT07384260 — The Effect of Probiotics on Gut Microbiota Changes in Healthy Chinese Adults During Short-Term European Travel: A Random · Phase 2 · not yet recruiting
NCT07498127 — Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study · Phase 2 · enrolling by invitation
NCT07378852 — Integrated Study on Gut Microbiota, Immune Indicators, and Trace Elements in Children With Respiratory Tract Infections · not yet recruiting
NCT07297966 — Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Y · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05734417 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Min-Tze LIONG
Last refreshed: 4 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05734417.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing